Tri Star Group

TriStar Technology Group offers biomarker services for oncology research and development. The company provides biological samples, including FFPE blocks, tissue microarrays, and plasma, coupled with annotated clinical and molecular data. TriStar also delivers contract research organization capabilities, performing analyses such as IHC, NGS, and digital spatial profiling for specimen examination.

Milan Bhagat founded TriStar Technology Group in 2003; Dr. Guido Sauter joined as co-founder in 2004. They identified a critical gap in oncology research: difficulty accessing quality biospecimens and analytical support. Their insight was to build a reliable platform for these resources, accelerating drug and diagnostic development.

TriStar Technology Group serves pharmaceutical, biotechnology, diagnostics, and AI firms. It helps clients advance oncology therapeutics and diagnostics. The company's vision is to remain a leading resource for biospecimens and data, fostering breakthroughs in cancer understanding and treatment.